The Global Health Supply Chain Summit has convened annually since 2008 (starting as a workshop, now a three-day conference) on designing and managing end-to-end health commodity supply chains in low- and middle-income countries, with a standing emphasis on Africa. Its secretariat sits at the University of Michigan's Ross School of Business, and it draws roughly 400 participants. The 2026 edition carries the theme 'Health Supply Chains for the Next Era: Rethinking Policy, Markets, Capital, and Access.'
Vaccine and immunization cold chain, biologics distribution, and last-mile storage in resource-limited settings are core subject matter, so this is where donor-funded and ministry cold chain strategy gets debated rather than sold. Practitioners take away field-tested approaches to storage capacity, temperature integrity, and distribution in weak-infrastructure environments. Optional in-country site visits on 16 November add operational context.
The room mixes academics with implementers: ministry-of-health supply chain units, procurement and distribution agencies, and global health organizations. Represented bodies include GAVI, PATH, and manufacturers such as Pfizer and Sanofi. Attendance skews toward public health logisticians, program managers, and technical advisors working in or on LMIC health systems.
Be the first to raise your hand.